Cabometyx® in Combination with Nivolumab Shows Durable Survival Benefits At Over Three-years’ Follow-up in First-line Advanced Renal Cell Carcinoma

Media coverage

• Title	Cabometyx® in Combination with Nivolumab Shows Durable Survival Benefits At Over Three-years’ Follow-up in First-line Advanced Renal Cell Carcinoma
  Media name/outlet	Newswire Today
  Country/Territory	Canada
  Date	14/02/23
  URL	ct.moreover.com/?a=50010427271&p=1gw&v=1&x=ThoxRbXWbz4LbC0ulhcywQ
  Persons	Mauricio Burotto

• Title	Cabometyx® in Combination with Nivolumab Shows Durable Survival Benefits At Over Three-years’ Follow-up in First-line Advanced Renal Cell Carcinoma
  Media name/outlet	PRZOOM - Newswire
  Country/Territory	United States
  Date	14/02/23
  URL	ct.moreover.com/?a=50010283321&p=1gw&v=1&x=2Y-sujcyc6EwhEmXYiPi3w
  Persons	Mauricio Burotto